Molecular and cellular adaptations to exercise training in skeletal muscle from cancer patients treated with chemotherapy. 2019

Andreas Buch Møller, and Simon Lønbro, and Jean Farup, and Thomas Schmidt Voss, and Nikolaj Rittig, and Jakob Wang, and Inger Højris, and Ulla Ramer Mikkelsen, and Niels Jessen
Research Laboratory for Biochemical Pathology, Department of Clinical Medicine, HEALTH, Aarhus University Hospital, Palle Juul-Jensen Blvd., 8200, Aarhus N, Denmark.

BACKGROUND A growing body of evidence suggests that exercise training has beneficial effects in cancer patients. The aim of the present study was to investigate the molecular basis underlying these beneficial effects in skeletal muscle from cancer patients. METHODS We investigated expression of selected proteins involved in cellular processes known to orchestrate adaptation to exercise training by western blot. Skeletal muscle biopsies were sampled from ten cancer patients before and after 4-7 weeks of ongoing chemotherapy, and subsequently after 10 weeks of continued chemotherapy in combination with exercise training. Biopsies from ten healthy matched subjects served as reference. RESULTS The expression of the insulin-regulated glucose transporter, GLUT4, increased during chemotherapy and continued to increase during exercise training. A similar trend was observed for ACC, a key enzyme in the biosynthesis and oxidation of fatty acids, but we did not observe any changes in other regulators of substrate metabolism (AMPK and PDH) or mitochondrial proteins (Cyt-C, COX-IV, SDHA, and VDAC). Markers of proteasomal proteolysis (MURF1 and ATROGIN-1) decreased during chemotherapy, but did not change further during chemotherapy combined with exercise training. A similar pattern was observed for autophagy-related proteins such as ATG5, p62, and pULK1 Ser757, but not ULK1 and LC3BII/LC3BI. Phosphorylation of FOXO3a at Ser318/321 did not change during chemotherapy, but decreased during exercise training. This could suggest that FOXO3a-mediated transcriptional regulation of MURF1 and ATROGIN-1 serves as a mechanism by which exercise training maintains proteolytic systems in skeletal muscle in cancer patients. Phosphorylation of proteins that regulate protein synthesis (mTOR at Ser2448 and 4EBP1 at Thr37/46) increased during chemotherapy and leveled off during exercise training. Finally, chemotherapy tended to increase the number of satellite cells in type 1 fibers, without any further change during chemotherapy and exercise training. Conversely, the number of satellite cells in type 2 fibers did not change during chemotherapy, but increased during chemotherapy combined with exercise training. CONCLUSIONS Molecular signaling cascades involved in exercise training are disturbed during cancer and chemotherapy, and exercise training may prevent further disruption of these pathways. BACKGROUND The study was approved by the local Scientific Ethics Committee of the Central Denmark Region (Project ID: M-2014-15-14; date of approval: 01/27/2014) and the Danish Data Protection Agency (case number 2007-58-0010; date of approval: 01/28/2015). The trial was registered at http//www.clinicaltrials.gov (registration number: NCT02192216; date of registration 07/17-2014).

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008931 Mitochondria, Muscle Mitochondria of skeletal and smooth muscle. It does not include myocardial mitochondria for which MITOCHONDRIA, HEART is available. Sarcosomes,Mitochondrion, Muscle,Muscle Mitochondria,Muscle Mitochondrion,Sarcosome
D009124 Muscle Proteins The protein constituents of muscle, the major ones being ACTINS and MYOSINS. More than a dozen accessory proteins exist including TROPONIN; TROPOMYOSIN; and DYSTROPHIN. Muscle Protein,Protein, Muscle,Proteins, Muscle
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D015444 Exercise Physical activity which is usually regular and done with the intention of improving or maintaining PHYSICAL FITNESS or HEALTH. Contrast with PHYSICAL EXERTION which is concerned largely with the physiologic and metabolic response to energy expenditure. Aerobic Exercise,Exercise, Aerobic,Exercise, Isometric,Exercise, Physical,Isometric Exercise,Physical Activity,Acute Exercise,Exercise Training,Activities, Physical,Activity, Physical,Acute Exercises,Aerobic Exercises,Exercise Trainings,Exercise, Acute,Exercises,Exercises, Acute,Exercises, Aerobic,Exercises, Isometric,Exercises, Physical,Isometric Exercises,Physical Activities,Physical Exercise,Physical Exercises,Training, Exercise,Trainings, Exercise
D046988 Proteasome Endopeptidase Complex A large multisubunit complex that plays an important role in the degradation of most of the cytosolic and nuclear proteins in eukaryotic cells. It contains a 700-kDa catalytic sub-complex and two 700-kDa regulatory sub-complexes. The complex digests ubiquitinated proteins and protein activated via ornithine decarboxylase antizyme. 20S Proteasome,Ingensin,Macropain,Macroxyproteinase,Multicatalytic Endopeptidase Complex,Multicatalytic Proteinase,Prosome,Proteasome,Complex, Multicatalytic Endopeptidase,Complex, Proteasome Endopeptidase,Endopeptidase Complex, Multicatalytic,Endopeptidase Complex, Proteasome,Proteasome, 20S,Proteinase, Multicatalytic

Related Publications

Andreas Buch Møller, and Simon Lønbro, and Jean Farup, and Thomas Schmidt Voss, and Nikolaj Rittig, and Jakob Wang, and Inger Højris, and Ulla Ramer Mikkelsen, and Niels Jessen
November 2010, The journals of gerontology. Series A, Biological sciences and medical sciences,
Andreas Buch Møller, and Simon Lønbro, and Jean Farup, and Thomas Schmidt Voss, and Nikolaj Rittig, and Jakob Wang, and Inger Højris, and Ulla Ramer Mikkelsen, and Niels Jessen
January 2016, Experimental physiology,
Andreas Buch Møller, and Simon Lønbro, and Jean Farup, and Thomas Schmidt Voss, and Nikolaj Rittig, and Jakob Wang, and Inger Højris, and Ulla Ramer Mikkelsen, and Niels Jessen
July 2023, Physiological reviews,
Andreas Buch Møller, and Simon Lønbro, and Jean Farup, and Thomas Schmidt Voss, and Nikolaj Rittig, and Jakob Wang, and Inger Højris, and Ulla Ramer Mikkelsen, and Niels Jessen
October 2016, Exercise and sport sciences reviews,
Andreas Buch Møller, and Simon Lønbro, and Jean Farup, and Thomas Schmidt Voss, and Nikolaj Rittig, and Jakob Wang, and Inger Højris, and Ulla Ramer Mikkelsen, and Niels Jessen
December 1991, Trends in cardiovascular medicine,
Andreas Buch Møller, and Simon Lønbro, and Jean Farup, and Thomas Schmidt Voss, and Nikolaj Rittig, and Jakob Wang, and Inger Højris, and Ulla Ramer Mikkelsen, and Niels Jessen
August 1998, Annals of medicine,
Andreas Buch Møller, and Simon Lønbro, and Jean Farup, and Thomas Schmidt Voss, and Nikolaj Rittig, and Jakob Wang, and Inger Højris, and Ulla Ramer Mikkelsen, and Niels Jessen
June 1997, Journal of applied physiology (Bethesda, Md. : 1985),
Andreas Buch Møller, and Simon Lønbro, and Jean Farup, and Thomas Schmidt Voss, and Nikolaj Rittig, and Jakob Wang, and Inger Højris, and Ulla Ramer Mikkelsen, and Niels Jessen
January 2021, Frontiers in aging,
Andreas Buch Møller, and Simon Lønbro, and Jean Farup, and Thomas Schmidt Voss, and Nikolaj Rittig, and Jakob Wang, and Inger Højris, and Ulla Ramer Mikkelsen, and Niels Jessen
December 2005, Chest,
Andreas Buch Møller, and Simon Lønbro, and Jean Farup, and Thomas Schmidt Voss, and Nikolaj Rittig, and Jakob Wang, and Inger Højris, and Ulla Ramer Mikkelsen, and Niels Jessen
December 2023, Journal of cachexia, sarcopenia and muscle,
Copied contents to your clipboard!